InvestorsHub Logo
Followers 43
Posts 2425
Boards Moderated 0
Alias Born 02/09/2016

Re: gestalt2 post# 28728

Saturday, 09/15/2018 2:46:19 PM

Saturday, September 15, 2018 2:46:19 PM

Post# of 233271
gestalt2- I appreciate your thoughts. I am also baffled with the FDA. 4 years folks on Pro 140 with no failures...only to want more from CYDY. This definitely makes a long term shareholder question what's going on. I did like Nader explaining the increase dosage from a Dr within the trials telling him there were no injection site side effects and c'mon increase it.
An investigation columnist could really write a good one on behalf of HIV patients not fairing well on available meds while this tic tocs in the FDA's hands. As for Nader, his comment of being on the goal line was tough to wrap around till Pestell used end zone.
IMO- GVHD, I would shelve it also. Save the money. Part of the BO package. Let the buyer pursue the opportunity to develop. Core assets are HIV and now Oncology with it in a few weeks. That's the package.
Chump
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News